|
1
|
Lordick F and Janjigian YY: Clinical
impact of tumour biology in the management of gastroesophageal
cancer. Nat Rev Clin Oncol. 13:348–360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shah MA: Gastrointestinal cancer: Targeted
therapies in gastric cancer-the dawn of a new era. Nat Rev Clin
Oncol. 11:10–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kremmidiotis G, Baker E, Crawford J, Eyre
HJ, Nahmias J and Callen DF: Localization of human cadherin genes
to chromosome regions exhibiting cancer-related loss of
heterozygosity. Genomics. 49:467–471. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Okazaki M, Takeshita S, Kawai S, Kikuno R,
Tsujimura A, Kudo A and Amann E: Molecular cloning and
characterization of OB-cadherin, a new member of cadherin family
expressed in osteoblasts. J Biol Chem. 269:12092–12098.
1994.PubMed/NCBI
|
|
5
|
Kimura Y, Matsunami H, Inoue T, Shimamura
K, Uchida N, Ueno T, Miyazaki T and Takeichi M: Cadherin-11
expressed in association with mesenchymal morphogenesis in the
head, somite, and limb bud of early mouse embryos. Dev Biol.
169:347–358. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hoffmann I and Balling R: Cloning and
expression analysis of a novel mesodermally expressed cadherin. Dev
Biol. 169:337–346. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chu K, Cheng CJ, Ye X, Lee YC, Zurita AJ,
Chen DT, Yu-Lee LY, Zhang S, Yeh ET, Hu MC, et al: Cadherin-11
promotes the metastasis of prostate cancer cells to bone. Mol
Cancer Res. 6:1259–1267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang CF, Lira C, Chu K, Bilen MA, Lee YC,
Ye X, Kim SM, Ortiz A, Wu FL, Logothetis CJ, et al: Cadherin-11
increases migration and invasion of prostate cancer cells and
enhances their interaction with osteoblasts. Cancer Res.
70:4580–4589. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Assefnia S, Dakshanamurthy S, Guidry Auvil
JM, Hampel C, Anastasiadis PZ, Kallakury B, Uren A, Foley DW, Brown
ML, Shapiro L, et al: Cadherin-11 in poor prognosis malignancies
and rheumatoid arthritis: Common target, common therapies.
Oncotarget. 5:1458–1474. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakajima G, Patino-Garcia A, Bruheim S, Xi
Y, San Julian M, Lecanda F, Sierrasesumaga L, Müller C, Fodstad O
and Ju J: CDH11 expression is associated with survival in patients
with osteosarcoma. Cancer Genomics Proteomics. 5:37–42.
2008.PubMed/NCBI
|
|
11
|
Rodríguez-Paredes M and Esteller M: Cancer
epigenetics reaches mainstream oncology. Nat Med. 17:330–339. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carmona FJ, Villanueva A, Vidal A, Muñoz
C, Puertas S, Penin RM, Gomà M, Lujambio A, Piulats JM, Mesía R, et
al: Epigenetic disruption of cadherin-11 in human cancer
metastasis. J Pathol. 228:230–240. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sepulveda JL, Gutierrez-Pajares JL, Luna
A, Yao Y, Tobias JW, Thomas S, Woo Y, Giorgi F, Komissarova EV,
Califano A, et al: High-definition CpG methylation of novel genes
in gastric carcinogenesis identified by next-generation sequencing.
Mod Pathol. 29:182–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Washington K: 7th edition of
the AJCC cancer staging manual: Stomach. Ann Surg Oncol.
17:3077–3079. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang W, Hsu S and Huang H, Sun Y, Chou C,
Weng S and Huang H: MethHC: A database of DNA methylation and gene
expression in human cancer. Nucleic Acids Res. 43:D856–D861. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:l12013. View Article : Google Scholar
|
|
21
|
Xie C, Mao X, Huang J, Ding Y, Wu J, Dong
S, Kong L, Gao G, Li C and Wei L: KOBAS 2.0: A web server for
annotation and identification of enriched pathways and diseases.
Nucleic Acids Res. 39:W316–W322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sherman BT and Lempicki RA: Systematic and
integrative analysis of large gene lists using DAVID bioinformatics
resources. Nat Protoc. 4:442009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kent WJ, Sugnet CW, Furey TS, Roskin KM,
Pringle TH, Zahler AM and Haussler D: The human genome browser at
UCSC. Genome Res. 12:996–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stormo GD: DNA binding sites:
Representation and discovery. Bioinformatics. 16:16–23. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yanaka Y, Muramatsu T, Uetake H, Kozaki K
and Inazawa J: miR-544a induces epithelial-mesenchymal transition
through the activation of WNT signaling pathway in gastric cancer.
Carcinogenesis. 36:1363–1371. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao P, Xing AY, Zhou GY, Zhang TG, Zhang
JP, Gao C, Li H and Shi DB: The molecular mechanism of microRNA-145
to suppress invasion-metastasis cascade in gastric cancer.
Oncogene. 32:491–501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shibata T, Ochiai A, Gotoh M, Machinami R
and Hirohashi S: Simultaneous expression of cadherin-11 in
signet-ring cell carcinoma and stromal cells of diffuse-type
gastric cancer. Cancer Lett. 99:147–153. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sandoval-Bórquez A, Polakovicova I,
Carrasco-Véliz N, Lobos-González L, Riquelme I, Carrasco-Avino G,
Bizama C, Norero E, Owen GI, Roa JC and Corvalán AH:
MicroRNA-335-5p is a potential suppressor of metastasis and
invasion in gastric cancer. Clin Epigenetics. 9:1142017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alimperti S and Andreadis ST: CDH2 and
CDH11 act as regulators of stem cell fate decisions. Stem Cell Res.
14:270–282. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin YL, Gui SL and Ma JG: Aberrant
methylation of CDH11 predicts a poor outcome for patients with
bladder cancer. Oncol Lett. 10:647–652. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yao J, Deng B, Zheng L, Dou L, Guo Y and
Guo K: miR-27b is upregulated in cervical carcinogenesis and
promotes cell growth and invasion by regulating CDH11 and
epithelial-mesenchymal transition. Oncol Rep. 35:1645–1651. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee Y, Bilen MA, Yu G, Lin S, Huang C,
Ortiz A, Cho H, Song JH, Satcher RL, Kuang J, et al: Inhibition of
cell adhesion by a cadherin-11 antibody thwarts bone metastasis.
Mol Cancer Res. 11:1401–1411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang JX, He WL, Feng ZH, Chen DL, Gao Y,
He Y, Qin K, Zheng ZS, Chen C, Weng HW, et al: A positive feedback
loop consisting of C12orf59/NF-κB/CDH11 promotes gastric cancer
invasion and metastasis. J Exp Clin Canc Res. 38:1642019.
View Article : Google Scholar
|
|
35
|
Ceteci F, Ceteci S, Karreman C, Kramer BW,
Asan E, Götz R and Rapp UR: Disruption of tumor cell adhesion
promotes angiogenic switch and progression to micrometastasis in
RAF-driven murine lung cancer. Cancer Cell. 12:145–159. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang Y, Li L, Zhu J, Kuang H, Dong S,
Wang H, Zhang X and Zhou Y: In vitro observations of self-assembled
ECM-mimetic bioceramic nanoreservoir delivering rFN/CDH to modulate
osteogenesis. Biomaterials. 33:7468–7477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jia D, Jing Y, Zhang Z, Liu L, Ding J,
Zhao F, Ge C, Wang Q, Chen T, Yao M, et al: Amplification of
MPZL1/PZR promotes tumor cell migration through Src-mediated
phosphorylation of cortactin in hepatocellular carcinoma. Cell Res.
24:204–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Moon H, Ju H, Chung SI, Cho KJ, Eun JW,
Nam SW, Han K, Calvisi DF and Ro SW: Transforming growth factor-β
promotes liver tumorigenesis in mice via up-regulation of snail.
Gastroenterology. 153:1378–1391. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Janku F, Yap TA and Meric-Bernstam F:
Targeting the PI3K pathway in cancer: Are we making headway? Nat
Rev Clin Oncol. 15:273–291. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ordóñez-Morán P, Dafflon C, Imajo M,
Nishida E and Huelsken J: HOXA5 counteracts stem cell traits by
inhibiting Wnt signaling in colorectal cancer. Cancer Cell.
28:815–829. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jendrossek V: Targeting apoptosis pathways
by Celecoxib in cancer. Cancer Lett. 332:313–324. 2013. View Article : Google Scholar : PubMed/NCBI
|
